AUTOANTIBODIES' TITRE MODULATION BY ANTI-BLYS TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Cavazzana, Ilaria [1 ]
Kumar, Rajesh [2 ]
Panaro, Salvatore [2 ]
Pozzari, Chiara [2 ]
Ottaviani, Roberta [2 ]
Fredi, Micaela [1 ,2 ]
Piantoni, Silvia [2 ]
Andreoli, Laura [1 ]
Tincani, Angela [1 ]
Franceschini, Franco [1 ]
机构：
[1] ASST Spedali Civili, Rheumatol & Clin Immunol, Brescia, Italy
[2] Univ Brescia, Clin & Expt Sci Dept, Rheumatol Chair, Brescia, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
BELIMUMAB;
D O I：
10.1136/annrheumdis-2019-eular.2613
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0481
引用
收藏
页码：1704 / 1704
页数：1
相关论文
共 50 条
  • [1] Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus
    Cavazzana, I
    Kumar, R.
    Pozzari, C.
    Ottaviani, R.
    Fredi, M.
    Piantom, S.
    Andreoli, L.
    Tincani, A.
    Franceschini, F.
    LUPUS, 2019, 28 (09) : 1074 - 1081
  • [2] Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus Patients
    Sthoeger, Zev
    Lorber, Margalit
    Tal, Yuval
    Toubi, Elias
    Amital, Howard
    Kivity, Shaye
    Langevitz, Pnina
    Asher, Ilan
    Elbirt, Daniel
    Levin, Nancy Agmon
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (01): : 44 - 48
  • [3] AUTOANTIBODIES' TITRE CHANGES DURING ANTIBLYS TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Cavazzana, I.
    Pozzari, C.
    Kumar, R.
    Ottaviani, R.
    Fredi, M.
    Piantoni, S.
    Tincani, A.
    Franceschini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : A2 - A3
  • [4] The discovery and development of belimumab: the anti-BLyS–lupus connection
    William Stohl
    David M Hilbert
    Nature Biotechnology, 2012, 30 : 69 - 77
  • [5] Targeting BLyS in Systemic Lupus Erythematosus
    Liu, Yaoyang
    La Cava, Antonio
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2012, 6 (02) : 91 - 96
  • [6] Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
    Howe, Hwee Siew
    Leung, Bernard Pui Lam
    CELLS, 2020, 9 (01)
  • [7] Anti-DNA autoantibodies and systemic lupus erythematosus
    Blatt, NB
    Glick, GD
    PHARMACOLOGY & THERAPEUTICS, 1999, 83 (02) : 125 - 139
  • [8] BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus
    Fairfax, Kirsten
    Mackay, Ian R.
    Mackay, Fabienne
    IUBMB LIFE, 2012, 64 (07) : 595 - 602
  • [9] Belimumab: A BLyS-Specific Inhibitor for the Treatment of Systemic Lupus Erythematosus
    Dennis, G. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (01) : 143 - 149
  • [10] BELIMUMAB, A BLyS-SPECIFIC INHIBITOR FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Espinosa, C.
    Cervera, R.
    DRUGS OF TODAY, 2010, 46 (12) : 891 - 899
12345